Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
If brand-name medications are out of your budget and you want something between the lowest-cost and highest-cost compounded options, VivioMD's pricing may fit your financial situation
Hyper-restrictive diets aren't necessary or recommendedGLP-1 naturally reduces appetite
On-treatment gain is possible
When discussing retatrutide with a healthcare professional, it is helpful to: Share your full cardiovascular history , including any previous heart conditions, arrhythmias, or relevant family history Bring a list of your current medications , as the heart rate effects of retatrutide may be relevant where rate-modifying drugs are already prescribed Ask about eligibility for clinical trials , as your GP or specialist may be able to refer you to a trial centre if you meet the inclusion criteria Discuss your overall cardiometabolic risk , including blood pressure, cholesterol, HbA1c, and BMI, to contextualise whether a drug of this class might be appropriate for you in the future For clinicians, current NICE guidance relevant to this area includes NICE CG189 (Obesity: identification, assessment and management), NICE TA875 (Semaglutide for managing overweight and obesity), and NICE NG28 (Type 2 diabetes in adults: management)
GLP-1 regulates glucose homeostasis by inhibiting glucagon, stimulating insulin release, increasing insulin biosynthesis, increasing cell proliferation, and decreasing cell apoptosis in rodents (40)
